Clinical Research and Medical
Information on the BT Test

The BT Test®, is not a genetic test. Rather, it detects and measures key blood-based protein biomarkers in the blood that are associated with breast cancer development and growth. Using a proprietary analytical relational algorithm, the test has demonstrated the ability to detect the actual presence of breast cancer with a high level of accuracy.

The BT Test has successfully demonstrated in its clinical studies an accuracy of 97% in women 49 years of age and younger and 86% in women 50 years of age and older. The clinical studies involved both breast cancer-positive and non-breast cancer patients; the latter group being comprised of both healthy women and those with benign breast conditions.

For more information on the BT Test's clinical study findings, please download our clinical study summary overview